Resources
News feed
What is the future for hepatitis treatments? And how we can fund hepatitis programmes?
Discussions around hepatitis are dominated by the pioneering new treatments rapidly transforming the landscape and the ensuing heated discussions...
How does the Alliance really represent hepatitis patients?
The World Hepatitis Alliance prides itself as the true voice of hepatitis patients living all over the world. All our work is overseen by an...
How will 2015 be a defining year for the Alliance?
Viral hepatitis is a global killer with alarming mortality rates, yet an increased global commitment to tackling the disease and ground-breaking new...
Supporting the development of national action plans in South America
Government commitment to comprehensive national action plans is key to addressing the burden of viral hepatitis. To support the development of...
Promoting screening among high risk communities with new multi-lingual tool
In Europe, migrant populations are disproportionally affected by hepatitis B and C. Crucial to reducing the burden is improving screening among these...
Joining expert committees to promote harm reduction
Harm reduction policies are proven to save lives. Globally, as many as 67% of People Who Inject Drugs (PWIDs) have hepatitis C and an additional 8.4...
World Hepatitis Alliance’s ever-growing membership base
Central to the success of the World Hepatitis Alliance are our member groups around the world. To stimulate political interest in and action on...
Assisting WHO in the development of a global strategy
World Health Organization Member States have urged WHO to develop a comprehensive global strategy on hepatitis. To assist in the development of this...
Exploring new treatment developments and innovative ways to finance healthcare
New therapeutic developments are revolutionising the way hepatitis is treated. But with a global lack of funding, how can these pioneering new drugs...